Antidrug Antibodies in Patients Treated with Alirocumab.

Roth, Eli M; Goldberg, Anne C; Catapano, Alberico L; Torri, Albert; Yancopoulos, George D; Stahl, Neil; Brunet, Aurélie; Lecorps, Guillaume; Colhoun, Helen M

Roth, Eli M; Goldberg, Anne C; Catapano, Alberico L; Torri, Albert; Yancopoulos, George D; Stahl, Neil; Brunet, Aurélie; Lecorps, Guillaume; Colhoun, Helen M.

Afiliação

Roth EM; Sterling Research Group, Cincinnati, OH eroth@sterlingresearch.org.
Goldberg AC; Washington University School of Medicine, St. Louis, MO.
Catapano AL; University of Milan Multimedica IRCCS, Milan, Italy.
Torri A; Regeneron Pharmaceuticals, Tarrytown, NY.
Yancopoulos GD; Regeneron Pharmaceuticals, Tarrytown, NY.
Stahl N; Regeneron Pharmaceuticals, Tarrytown, NY.
Brunet A; Sanofi, Bridgewater, NJ.
Lecorps G; Sanofi, Chilly Mazarin, France.
Colhoun HM; University of Edinburgh, Edinburgh, United Kingdom.

N Engl J Med ; 376(16): 1589-90, 2017 04 20.

Article em En | MEDLINE | ID: mdl-28304229

Assuntos

Anticorpos Monoclonais; Anticolesterolemiantes; Anticorpos; Humanos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Monoclonais / Anticolesterolemiantes Limite: Humans Idioma: En Revista: N Engl J Med Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google